← FDA DRUG APPROVALS

FDA ANDA · ANDA206575

CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA206575
TYPE
ANDA
ORIGINAL APPROVAL
2019-08-19
LATEST ACTION
2023-09-07
ROUTE
TOPICAL
DOSAGE FORM
GEL
MARKETING STATUS
Prescription

Products

CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDEPrescription
BENZOYL PEROXIDE 2.5%, CLINDAMYCIN PHOSPHATE EQ 1.2% BASE · GEL · TOPICAL

Approval history

2023-09-07Labeling · Supplement 2 · standardAP
2019-08-19UNKNOWN · Original · standard — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →